![]() |
6th International AIDS ConferenceSan Francisco, California, USA — June 20-23, 1990 |
Int Conf AIDS 1990 Jun 20-23; 6:335 (abstract no. 1085)
Nair BC, Ford G, Kalyanaraman V, Zafari M, Fang C, Gallo R, Sarngadharan M; Advanced BioScience Laboratories, Inc., Kensington, MD USA
OBJECTIVE: To evaluate the usefulness of purified native envelope antigen in HIV serodiagnosis.
METHODS: An EIA was developed using purified native gp160. This system was compared for its sensitivity and specificity with EIAs that use viral lysate and recombinant proteins as antigens.
RESULTS: The gp160 assay was determined to be highly specific as 1) 998 of 1,000 sera from healthy blood donors were negative; the 2 were confirmed positive by Western blot (WB) assay, 2) 55 sera that contain antibodies likely to produce false positive reactions were all found to be negative, 3) the results of gp160 EIA coincided with WB characteristics of 398 sera. The assay was 2-10 times more sensitive than EIAs that use virus lysate as antigen on panels of diluted sera. The assay detected antibodies in early bleeds of a seroconverter which were not detected by commercial EIAs that use solubilized virus or recombinant envelope protein as antigen.
CONCLUSION: gp160 EIA is highly specific and sensitive. The native antigen appears to be important in the earliest detection of HIV antibodies during early seroconversion. The highly purified native envelope antigen may be useful in HIV serodiagnosis.
900620
1085
Copyright © 1990 - International AIDS Society (IAS). Reproduction of this abstract (other than one copy for personal reference) must be cleared through the IAS.